Letrozole in Combination with Trastuzumab Is Superior to Letrozole Monotherapy as First Line Treatment in Patients with Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer (MBC) - Results of the eLEcTRA Trial
Dokumenttyp:
Meeting Abstract
Autor(en):
Huober, J; Fasching, P; Paepke, S; Kubista, E; Barsoum, M; Wallwiener, D; Harbeck, N